Dow Jones

38 589,16

-0,15%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

HUMA

Humacyte (HUMA)

Humacyte Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:HUMA

1 2 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
08/03/2024	22h03	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:HUMA	Humacyte Inc
04/03/2024	12h53	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HUMA	Humacyte Inc
29/02/2024	22h11	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:HUMA	Humacyte Inc
12/12/2023	22h10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMA	Humacyte Inc
09/11/2023	22h28	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HUMA	Humacyte Inc
12/09/2023	02h03	Dow Jones News	Stocks to Watch: Oracle, Acelyrin, Humacyte	NASDAQ:HUMA	Humacyte Inc
17/08/2023	22h28	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:HUMA	Humacyte Inc
31/07/2023	19h28	Dow Jones News	Humacyte Shares Rise 8% After Completing Enrollment in Phase 2/3 Trial	NASDAQ:HUMA	Humacyte Inc
16/06/2023	22h14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:HUMA	Humacyte Inc
15/06/2023	22h25	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:HUMA	Humacyte Inc
09/06/2023	22h05	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:HUMA	Humacyte Inc
08/06/2023	22h07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:HUMA	Humacyte Inc
24/05/2023	22h53	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:HUMA	Humacyte Inc
12/05/2023	22h20	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:HUMA	Humacyte Inc
28/04/2023	12h45	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:HUMA	Humacyte Inc
24/03/2023	13h51	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:HUMA	Humacyte Inc
10/11/2022	16h30	TipRanks	Analysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT) and Humacyte (HUMA)	NASDAQ:HUMA	Humacyte Inc
19/09/2022	22h42	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:HUMA	Humacyte Inc
15/09/2022	12h33	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:HUMA	Humacyte Inc
12/09/2022	12h31	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:HUMA	Humacyte Inc
09/09/2022	22h44	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:HUMA	Humacyte Inc
12/08/2022	18h25	TipRanks	Humacyte (HUMA) Gets a Buy from BTIG	NASDAQ:HUMA	Humacyte Inc
12/07/2022	11h36	TipRanks	BTIG Thinks Humacyte’s Stock is Going to Recover	NASDAQ:HUMA	Humacyte Inc
04/04/2022	23h23	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)	NASDAQ:HUMA	Humacyte Inc
29/03/2022	16h45	TipRanks	Analysts Offer Insights on Healthcare Companies: AKOUOS (AKUS) and Humacyte (HUMA)	NASDAQ:HUMA	Humacyte Inc
14/02/2022	22h44	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:HUMA	Humacyte Inc
09/02/2022	13h30	GlobeNewswire Inc.	Humacyte to Participate in Fireside Chat at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference	NASDAQ:HUMA	Humacyte Inc
31/01/2022	13h30	GlobeNewswire Inc.	Humacyte Announces Clinical Case Series Demonstrating Potential of Human Acellular Vessel™ (HAV™) to Expand Opportunities for Limb Salvage in Multiple Complex Vascular Reconstruction Scenarios	NASDAQ:HUMA	Humacyte Inc
28/01/2022	15h15	GlobeNewswire Inc.	Humacyte Announces Preclinical Results of Small-Diameter Human Acellular Vessel™ (HAV™) in Coronary Artery Bypass Grafting	NASDAQ:HUMA	Humacyte Inc
06/01/2022	13h30	GlobeNewswire Inc.	Humacyte Announces Presentation of First Eight Expanded Access Cases Using Human Acellular Vessel™ (HAV) for Treatment of Critical Limb Ischemia at 46th Annual Winter Meeting of the Vascular and Endovascular Surgery Society	NASDAQ:HUMA	Humacyte Inc